HELIUM, USP
Peakhelium, oxygen
NDAINHALATIONGAS
Approved
Jul 2013
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 4d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HELIUM, USP is an inhaled gas mixture combining helium and oxygen administered via inhalation for therapeutic purposes. The product is a non-drug gas therapeutic approved as a New Drug Application, indicating regulatory oversight of its composition and purity. It is used in clinical settings where reduced airway resistance and improved gas diffusion are therapeutically beneficial.
Peak
Product is at peak lifecycle stage with moderate competitive pressure (30%), indicating stable but not rapidly growing market opportunities.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
HELIUM, USP has zero linked job postings currently, indicating a niche market with limited career pipeline visibility. Working on this specialty gas therapeutic would position you in a highly specialized field requiring clinical respiratory expertise and healthcare systems knowledge.
Respiratory SpecialistClinical Affairs Manager
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.